Although these clinical manifestations may develop in a hyperuricemic individual at any point, about two-thirds or more of such individuals remain asymptomatic, never developing gout flares, tophaceous gout, acute or chronic hyperuricemic nephropathy, or uric acid nephrolithiasis.